NCT07188558Phase 3Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Study sponsor: Lyell Immunopharma, Inc. · LYEL

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-12Estimated
Enrollment · participants400Estimated
Source updated2026-11-04Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source